ICD-10-CM Billable Code

T47.0X3

Poisoning by histamine H2-receptor blockers, assault

Clinical Classification Guidelines

Medical Intelligence & Overview

Poisoning by histamine H2-receptor blockers, classified under ICD-10 code T47.0X3, involves an adverse reaction resulting from the overuse or accidental ingestion of medications that reduce stomach acid production. These drugs are commonly used to treat conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. While generally safe when used as prescribed, an overdose or accidental poisoning can lead to serious health complications, requiring immediate medical attention.

Causes & Symptoms

Clinical Causes: Accidental ingestion of excessive quantities of H2-receptor blockers by children or adults Intentional overdose in cases of self-harm or suicide attempts Misuse or abuse of medication for non-medical reasons Lack of awareness about proper dosage or storage of the medication Errors during medication dispensing or administration

Key Symptoms: Nausea and vomiting Dizziness or lightheadedness Confusion or altered mental state Reduced blood pressure (hypotension) Respiratory distress or difficulty breathing Seizures in severe cases Bradycardia (slowed heart rate) Fainting or loss of consciousness

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and medical history assessment. Healthcare providers may perform the following:

Treatment Protocols: Treatment primarily focuses on stabilizing the patient's condition and removing or neutralizing the poison. Medical interventions may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T47.0X3 a billable ICD-10 code?
Yes, T47.0X3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T47.0X3?
Clinical documentation must specify the nature of Poisoning by histamine H2-receptor blockers, assault and any associated comorbidities for accurate reporting.

Cite this Clinical Reference